Nika Pharmaceuticals, Inc (NIKA)
CIK 1145604 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nika Pharmaceuticals, Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 10, 2026 | 10-Q | 0001826466-26-000049 |
| May 12, 2026 | 10-Q | 0001826466-26-000039 |
| Mar 25, 2026 | 10-K | 0001826466-26-000026 |
| Aug 14, 2025 | 10-Q | 0001826466-25-000087 |
| May 13, 2025 | 10-Q | 0001826466-25-000058 |
| Apr 16, 2025 | 144 | 0002019433-25-000002 |
| Mar 31, 2025 | 10-K | 0001826466-25-000030 |
| Mar 19, 2025 | 4 | 0001826466-25-000024 |
| Nov 12, 2024 | 10-Q | 0001826466-24-000146 |
| Nov 1, 2024 | 10-Q/A | 0001826466-24-000136 |
| Oct 16, 2024 | 8-K | 0001826466-24-000131 |
| Oct 1, 2024 | 8-K | 0001826466-24-000128 |
| Sep 19, 2024 | RW | 0001826466-24-000125 |
| Sep 18, 2024 | 10-Q | 0001826466-24-000120 |
| Sep 16, 2024 | RW | 0001826466-24-000102 |
| Sep 12, 2024 | RW | 0001826466-24-000099 |
| Aug 27, 2024 | 8-K | 0001826466-24-000096 |
| Aug 14, 2024 | NT 10-Q | 0001826466-24-000077 |
| May 28, 2024 | 10-Q | 0001826466-24-000068 |
| May 16, 2024 | NT 10-Q | 0001826466-24-000065 |
| May 10, 2024 | 8-K | 0001826466-24-000056 |
| Apr 15, 2024 | 8-K | 0001826466-24-000050 |
| Apr 5, 2024 | S-4/A | 0001826466-24-000048 |
| Apr 1, 2024 | 10-K | 0001826466-24-000041 |
| Mar 19, 2024 | 4 | 0001826466-24-000035 |